University of Ulm
uni-ulm.deTotal trials
143
Active
29
Phase 3
15
Total enrollment
94,525
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Cytarabine | — | — | — | — | 10 | ||
| Daunorubicin | — | — | — | — | 5 | ||
| venetoclax | — | — | — | — | 2 | ||
| Standard chemotherapy | — | — | — | — | — | 2 | |
| CPX-351 | — | — | — | — | — | 1 | |
| Immunoglobulins | — | — | — | — | — | 1 | |
| Application of exosomes in a whole blood assay | — | — | — | — | — | 1 |
Next readouts
- 2025-07-31
- 2027-06
- 2027-09-01
- 2029-03
Top conditions
- Acute Myeloid Leukemia12
- Amyotrophic Lateral Sclerosis6
- Acute Myeloid Leukemia (AML)6
- Coronary Artery Disease6
- Sepsis4
- Critically Ill4
- Iron Deficiency3
- SIRS3
Frequently asked questions about University of Ulm
- How many clinical trials does University of Ulm have on ClinicalTrials.gov?
- University of Ulm is listed as the lead sponsor on 143 clinical trials in ClinicalTrials.gov, 29 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Ulm's trials are in Phase 3?
- 15 of University of Ulm's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does University of Ulm focus on?
- University of Ulm's most-studied conditions on ClinicalTrials.gov are Acute Myeloid Leukemia, Amyotrophic Lateral Sclerosis, Acute Myeloid Leukemia (AML), Coronary Artery Disease, Sepsis.
- When are University of Ulm's next clinical trial readouts?
- University of Ulm has 4 upcoming primary-completion readouts tracked here; the soonest is “Immune Modulation by Exosomes in COVID-19”, expected around 2025-07-31.